Critical roles of the Raf/MEK/ERK pathway in apoptosis and drug resistance

James A. McCubrey, Fred E. Bertrand, Linda S. Steelman, Fumin Chang, David M. Terrian, Richard A. Franklin

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The Ras/Raf/MEK/ERK pathway plays a critical role in the transmission of signals from growth factor receptors to the nucleus to regulate gene expression. Components of this pathway (e.g., Ras and B-Raf) are frequently mutated in human cancer. Mutations at upstream receptors (e.g., epidermal growth factor receptor [EGFR] and Flt-3) and chimeric chromosomal translocations (e.g., BCR-ABL), which transmit their signals through the Ras/Raf/MEK/ERK cascade were also frequently observed in human cancer. This pathway also interacts with other signaling pathways (e.g., PI3K/PTEN/Akt) to regulate cell growth. In some cells, mutation of PTEN may contribute to suppression of Raf/MEK/ERK because of the ability of Akt to phosphorylate and inactivate Raf-1. Other regulatory components of the Raf/MEK/ERK pathway (e.g., the Raf Kinase Inhibitor Protein, RKIP) may display altered expression during metastasis, which lead to activation of the pathway. This chapter describes the roles of the Raf/MEK/ERK pathway in signal transduction, prevention of apoptosis and induction of drug resistance.

Original languageEnglish (US)
Title of host publicationApoptosis, Cell Signaling, and Human Diseases
PublisherHumana Press
Pages101-134
Number of pages34
Volume2
ISBN (Print)1588296776, 9781588296771
DOIs
StatePublished - Dec 1 2007
Externally publishedYes

Fingerprint

MAP Kinase Signaling System
Mitogen-Activated Protein Kinase Kinases
Drug Resistance
Apoptosis
Phosphatidylethanolamine Binding Protein
Pharmaceutical Preparations
Genetic Translocation
Mutation
Growth Factor Receptors
Phosphatidylinositol 3-Kinases
Epidermal Growth Factor Receptor
Signal Transduction
Neoplasms
Signal transduction
Neoplasm Metastasis
Gene Expression
Cell growth
Gene expression
Growth
Chemical activation

Keywords

  • apoptosis
  • cell cycle
  • drug resistance
  • MAPK
  • Raf
  • signal transduction

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

McCubrey, J. A., Bertrand, F. E., Steelman, L. S., Chang, F., Terrian, D. M., & Franklin, R. A. (2007). Critical roles of the Raf/MEK/ERK pathway in apoptosis and drug resistance. In Apoptosis, Cell Signaling, and Human Diseases (Vol. 2, pp. 101-134). Humana Press. https://doi.org/10.1007/978-1-59745-199-4_5

Critical roles of the Raf/MEK/ERK pathway in apoptosis and drug resistance. / McCubrey, James A.; Bertrand, Fred E.; Steelman, Linda S.; Chang, Fumin; Terrian, David M.; Franklin, Richard A.

Apoptosis, Cell Signaling, and Human Diseases. Vol. 2 Humana Press, 2007. p. 101-134.

Research output: Chapter in Book/Report/Conference proceedingChapter

McCubrey, JA, Bertrand, FE, Steelman, LS, Chang, F, Terrian, DM & Franklin, RA 2007, Critical roles of the Raf/MEK/ERK pathway in apoptosis and drug resistance. in Apoptosis, Cell Signaling, and Human Diseases. vol. 2, Humana Press, pp. 101-134. https://doi.org/10.1007/978-1-59745-199-4_5
McCubrey JA, Bertrand FE, Steelman LS, Chang F, Terrian DM, Franklin RA. Critical roles of the Raf/MEK/ERK pathway in apoptosis and drug resistance. In Apoptosis, Cell Signaling, and Human Diseases. Vol. 2. Humana Press. 2007. p. 101-134 https://doi.org/10.1007/978-1-59745-199-4_5
McCubrey, James A. ; Bertrand, Fred E. ; Steelman, Linda S. ; Chang, Fumin ; Terrian, David M. ; Franklin, Richard A. / Critical roles of the Raf/MEK/ERK pathway in apoptosis and drug resistance. Apoptosis, Cell Signaling, and Human Diseases. Vol. 2 Humana Press, 2007. pp. 101-134
@inbook{38395130bfca4e9c814bef83be62ca28,
title = "Critical roles of the Raf/MEK/ERK pathway in apoptosis and drug resistance",
abstract = "The Ras/Raf/MEK/ERK pathway plays a critical role in the transmission of signals from growth factor receptors to the nucleus to regulate gene expression. Components of this pathway (e.g., Ras and B-Raf) are frequently mutated in human cancer. Mutations at upstream receptors (e.g., epidermal growth factor receptor [EGFR] and Flt-3) and chimeric chromosomal translocations (e.g., BCR-ABL), which transmit their signals through the Ras/Raf/MEK/ERK cascade were also frequently observed in human cancer. This pathway also interacts with other signaling pathways (e.g., PI3K/PTEN/Akt) to regulate cell growth. In some cells, mutation of PTEN may contribute to suppression of Raf/MEK/ERK because of the ability of Akt to phosphorylate and inactivate Raf-1. Other regulatory components of the Raf/MEK/ERK pathway (e.g., the Raf Kinase Inhibitor Protein, RKIP) may display altered expression during metastasis, which lead to activation of the pathway. This chapter describes the roles of the Raf/MEK/ERK pathway in signal transduction, prevention of apoptosis and induction of drug resistance.",
keywords = "apoptosis, cell cycle, drug resistance, MAPK, Raf, signal transduction",
author = "McCubrey, {James A.} and Bertrand, {Fred E.} and Steelman, {Linda S.} and Fumin Chang and Terrian, {David M.} and Franklin, {Richard A.}",
year = "2007",
month = "12",
day = "1",
doi = "10.1007/978-1-59745-199-4_5",
language = "English (US)",
isbn = "1588296776",
volume = "2",
pages = "101--134",
booktitle = "Apoptosis, Cell Signaling, and Human Diseases",
publisher = "Humana Press",

}

TY - CHAP

T1 - Critical roles of the Raf/MEK/ERK pathway in apoptosis and drug resistance

AU - McCubrey, James A.

AU - Bertrand, Fred E.

AU - Steelman, Linda S.

AU - Chang, Fumin

AU - Terrian, David M.

AU - Franklin, Richard A.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - The Ras/Raf/MEK/ERK pathway plays a critical role in the transmission of signals from growth factor receptors to the nucleus to regulate gene expression. Components of this pathway (e.g., Ras and B-Raf) are frequently mutated in human cancer. Mutations at upstream receptors (e.g., epidermal growth factor receptor [EGFR] and Flt-3) and chimeric chromosomal translocations (e.g., BCR-ABL), which transmit their signals through the Ras/Raf/MEK/ERK cascade were also frequently observed in human cancer. This pathway also interacts with other signaling pathways (e.g., PI3K/PTEN/Akt) to regulate cell growth. In some cells, mutation of PTEN may contribute to suppression of Raf/MEK/ERK because of the ability of Akt to phosphorylate and inactivate Raf-1. Other regulatory components of the Raf/MEK/ERK pathway (e.g., the Raf Kinase Inhibitor Protein, RKIP) may display altered expression during metastasis, which lead to activation of the pathway. This chapter describes the roles of the Raf/MEK/ERK pathway in signal transduction, prevention of apoptosis and induction of drug resistance.

AB - The Ras/Raf/MEK/ERK pathway plays a critical role in the transmission of signals from growth factor receptors to the nucleus to regulate gene expression. Components of this pathway (e.g., Ras and B-Raf) are frequently mutated in human cancer. Mutations at upstream receptors (e.g., epidermal growth factor receptor [EGFR] and Flt-3) and chimeric chromosomal translocations (e.g., BCR-ABL), which transmit their signals through the Ras/Raf/MEK/ERK cascade were also frequently observed in human cancer. This pathway also interacts with other signaling pathways (e.g., PI3K/PTEN/Akt) to regulate cell growth. In some cells, mutation of PTEN may contribute to suppression of Raf/MEK/ERK because of the ability of Akt to phosphorylate and inactivate Raf-1. Other regulatory components of the Raf/MEK/ERK pathway (e.g., the Raf Kinase Inhibitor Protein, RKIP) may display altered expression during metastasis, which lead to activation of the pathway. This chapter describes the roles of the Raf/MEK/ERK pathway in signal transduction, prevention of apoptosis and induction of drug resistance.

KW - apoptosis

KW - cell cycle

KW - drug resistance

KW - MAPK

KW - Raf

KW - signal transduction

UR - http://www.scopus.com/inward/record.url?scp=84900976803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900976803&partnerID=8YFLogxK

U2 - 10.1007/978-1-59745-199-4_5

DO - 10.1007/978-1-59745-199-4_5

M3 - Chapter

AN - SCOPUS:84900976803

SN - 1588296776

SN - 9781588296771

VL - 2

SP - 101

EP - 134

BT - Apoptosis, Cell Signaling, and Human Diseases

PB - Humana Press

ER -